These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15085749)

  • 1. Cytodiagnostic problems in uterine sarcoma. Analysis according to a novel classification of tumor growth types.
    Oda K; Okada S; Nei T; Shirai T; Takahashi M; Sano Y; Shiromizu K
    Acta Cytol; 2004; 48(2):181-6. PubMed ID: 15085749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytology of vaginal and uterine sarcomas.
    Ito E; Saito T; Suzuki T; Fujii M; Kudo R
    Acta Cytol; 2004; 48(5):601-7. PubMed ID: 15471250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Uterine sarcomas. Cytological diagnosis and differential diagnosis].
    Höffken H; Rummel HH; Hoppe L
    Fortschr Med; 1980 Sep; 98(36):1365-8. PubMed ID: 7461542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine sarcomas.
    Mbatani N; Olawaiye AB; Prat J
    Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleolar organizer regions in uterine sarcomas.
    Boquist LL
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(4):353-8. PubMed ID: 1566564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the relationship between adenosarcoma and carcinosarcoma and a hypothesis of the histogenesis of uterine sarcomas.
    Seidman JD; Chauhan S
    Int J Gynecol Pathol; 2003 Jan; 22(1):75-82. PubMed ID: 12496702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine sarcomas: a review.
    D'Angelo E; Prat J
    Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical survey of mismatch repair protein expression in uterine sarcomas and carcinosarcomas.
    Hoang LN; Ali RH; Lau S; Gilks CB; Lee CH
    Int J Gynecol Pathol; 2014 Sep; 33(5):483-91. PubMed ID: 25083964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcoma.
    Arita S; Kikkawa F; Kajiyama H; Shibata K; Kawai M; Mizuno K; Nagasaka T; Ino K; Nomura S
    Int J Gynecol Cancer; 2005; 15(2):329-36. PubMed ID: 15823121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of MR Imaging as a Tool to Differentiate between the Major Histological Types of Uterine Sarcomas.
    Sumi A; Terasaki H; Sanada S; Uchida M; Tomioka Y; Kamura T; Yano H; Abe T
    Magn Reson Med Sci; 2015; 14(4):295-304. PubMed ID: 26104072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
    D'Angelo E; Spagnoli LG; Prat J
    Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological analysis of c-kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpus.
    Winter WE; Seidman JD; Krivak TC; Chauhan S; Carlson JW; Rose GS; Birrer MJ
    Gynecol Oncol; 2003 Oct; 91(1):3-8. PubMed ID: 14529656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The stromal and myogenic sarcomas of the uterus (author's transl)].
    Dallenbach-Hellweg G
    Pathol Res Pract; 1980 Oct; 169(2):127-39. PubMed ID: 7443571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Histologic Factors in Carcinosarcomas of the Uterus: A Multi-institutional Study.
    Abdulfatah E; Lordello L; Khurram M; Van de Vijver K; Alosh B; Bandyopadhyay S; Oliva E; Ali-Fehmi R
    Int J Gynecol Pathol; 2019 May; 38(3):205-215. PubMed ID: 30958427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine sarcomas.
    Punnonen R; Lauslahti K; Pystynen P; Kauppila O
    Ann Chir Gynaecol Suppl; 1985; 197():11-4. PubMed ID: 3863523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Histopathologic and cytologic studies on uterine sarcomas (author's transl)].
    Izutsu T; Kagabu T; Sato K; Kubota T; Harada K; Nishiya I
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Dec; 33(12):2163-72. PubMed ID: 7338667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors.
    Wada H; Enomoto T; Fujita M; Yoshino K; Nakashima R; Kurachi H; Haba T; Wakasa K; Shroyer KR; Tsujimoto M; Hongyo T; Nomura T; Murata Y
    Cancer Res; 1997 Dec; 57(23):5379-85. PubMed ID: 9393763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of myocardin in the classification of mesenchymal tumors of the uterus.
    Liang J; Wu L; Xiao H; Li N; Wang H; Cheng C; Bai R; Zhao Y; Zheng H
    Int J Gynecol Pathol; 2010 Jan; 29(1):55-62. PubMed ID: 19952936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sarcomas and mixed mesodermal tumors of the uterus].
    Günthert AR
    Ther Umsch; 2011 Oct; 68(10):559-64. PubMed ID: 21968895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite instability in uterine sarcomas.
    Amant F; Dorfling CM; Dreyer L; Vergote I; Lindeque BG; Van Rensburg EJ
    Int J Gynecol Cancer; 2001; 11(3):218-23. PubMed ID: 11437928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.